Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

Abstract

Active tuberculosis may develop soon after the initiation of treatment with infliximab. Before prescribing the drug, physicians should screen patients for latent tuberculosis infection or disease.